Agile Therapeutics, Inc. Proceeds from Notes Payable
Agile Therapeutics, Inc. reported Proceeds from Notes Payable of $3.00 million for the 12-month period ending 2014-12-31, per its 10-K filed 2017-03-15.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromNotesPayable · last filed 2017-03-15
- Agile Therapeutics, Inc. proceeds from notes payable for the quarter ending 2014-12-31 was $0.00.
- Agile Therapeutics, Inc. proceeds from notes payable for the quarter ending 2014-09-30 was $0.00.
- Agile Therapeutics, Inc. proceeds from notes payable for fiscal 2014 was $3.00M.
- Agile Therapeutics, Inc. proceeds from notes payable for fiscal 2012 was $6.00M.
| Period end | Proceeds from Notes Payable 3 month | Proceeds from Notes Payable 6 month | Proceeds from Notes Payable 9 month | Proceeds from Notes Payable 12 month |
|---|---|---|---|---|
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | $0.00 derived: sum of 2 quarters · filed 2017-03-15 | $3.00M 10-K · filed 2017-03-15 | |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $3.00M 10-Q · filed 2015-11-09 | ||
| 2014-06-30 | $3.00M 10-Q · filed 2015-08-13 | |||
| 2012-12-31 | $6.00M 10-K · filed 2015-03-26 |